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Conclusions: PCR and DNA sequencing detected the
presence of H. hepaticus more often in liver biopsies with
HCV infection without than with concomitant HCC.
OL-049 Screening of proteins binding to HCV NS3
protein from human pancreas cDNA library by
yeast two-hybrid
C.C. Hu, J.Q. Zhang*, X.C. Wang, G.L. Li, Q. Wang,
J. Cheng. Institute of Infectious Diseases, Beijing Ditan
Hospital, Beijing 100011, China
Objective: To screen proteins of human pancreas cDNA
library interacting with HCV NS3 protein.
Methods: The library was amplifed, puriﬁed and evaluated,
and then the puried library plasmids were transformed
into yeast strain Y187. The reconstructed plasmid pGBKT7-
NS3 was transformed into yeast strain AH109 and
screened on the nutrient deﬁciency medium SD/-Trp.
The transformed AH109 mated with Y187 containing the
library plasmid. The diploid yeast cells were plated on
nutrient deﬁciency medium SD/-Trp/-Leu/-His/-Ade and
SD/-Trp/-Leu/-His/-Ade containing X-a-gal for selecting.
The plasmids in diploid yeast cells were extracted and
electrotransformed into E. coli DH5a. The plasmids in DH5a
were extracted, sequenced and analyzed by bioinformatic
methods.
Results: Eight proteins interacting with HCV NS3 were
found.
Conclusions: These results show that HCV NS3 protein may
be related with metabolism of glucose and lipid.
Supported by the National Natural Science Foundation of
China, No. 30600524.
OL-050 Extended Programme of Immunization (E.P.I) in
Pakistan; shadow shift from polio to hepatitis,
the threatening upcoming challenge
T. Hussain1 *, R. Ara2. 1Department of Cardiology, Union
Hospital, International Students/Doctors Building, Tongji
Medical College, Wuhan, China, 2Department of Law,
Islamabad, Pakistan
Background and Aims: In past, EPI-Pakistan focused primar-
ily on diseases like Polio/Measles/Mumps/Tuberculosis, but
as ﬁgures switched from 238 Polio, 0.3 Million Hepatitis-B
and nearly 0.45 Million Hepatitis-C registered cases in
1997 to 30 Polio, 5.3 Million Hepatitis-B and 4.9 Million
Hepatitis-C cases in 2007, government changed the policy,
making a stress over Hepatitis-B control.
HBV/HCV is well known to cause hepatitis/related
complications throughout the world, proving a threatening
challenge to developing countries. Study aim was to
estimate seropositivity levels of HBV/HCV among apparently
healthy young population.
Methods: Study was conducted at Holy-Family Hospital
Rawalpindi, Pakistan. Over a period of 6months, 500cases
aged between 20 40Years including 50Doctors and 450
routine blood-donors were screened after written-informed
consent. They had neither any sign nor symptom of
acute/chronic liver-disease. Samples were screened for
HBsAg and Anti-HCV-antibodies. Cases found positive for
HCV-Ab were interviewed for possible risk factors.
Results: Overall 52% were male, 6.4% positive for HBsAg,
male-female ratio 38:27, mean-age 24±4 years, 4.7%
positive for Anti-HCV-antibodies, mean-age 25±3 years and
0.33% positive for both. Overall infection-rate was 3.3%.
Prevalence-rate of Anti-HCV-antibodies (4.7%) was less than
HBsAg positivity (6.4%). There was no signiﬁcant overlap
(0.5%) between seropositivity of Anti-HCV with HBsAg,
reﬂecting different epidemiological-factors. Cases with
Anti-HCV antibodies were further evaluated; 56% were with
raised ALT, 79% had risk factors including blood-group testing
(71%), parenteral-medications/needle/prick-injuries (71%),
dental-procedures (19%), previous-surgery/tattoo-markings
(15%), unsafe-sex (19%) and multiple blood-transfusions
(2%). 7% gave no history of possible exposure. 16 doctors
positive for virus (14Hep-B and 2Hep-C), all gave history of
needle-prick injuries.
Conclusion: Hepatitis B-Vaccine inclusion in EPI-Pakistan
will decline its prevalence but HCV mostly spread via
health-care facilities, so behavior-modiﬁcation is superior
to clinical therapy as minimizing all types of needle-pricks
is advised till proper aseptic practice.
Acknowledgement: Dr. Abbas Hayat, Dr. Sara Tajammul, Dr.
Aamra Sartaj and Ali Mumtaz.
OL-051 Detect the gene expression inﬂuence after the
interaction between HCV NS4A and CAML with
microarray assay
Y.Q. Cheng*, Y. Liu, L. Wang, J. Cheng, D.P. Xu, Y.W. Zhong,
J.Z. Dai, X.D. Li. The 302 Hospital of PLA, Beijing 100039,
China
Aim: To understand gene expression inﬂuence after the
interaction between HCV NS4A and CAML.
Methods: The expressive vector of pCMV/Myc-NS4A
and pcDNA3.1/HisA-CAML were constructed by routine
molecular biological methods. The 293 cells were
transfected by pCMV/Myc-NS4A and pcDNA3.1/HisA-CAML,
respectively using lipofectamine. The total RNAwas isolated
and reverse transcribed. The cDNAs were subjected for
microarray screening.
Results: The expressive vector has been constructed
and conﬁrmed by restriction enzyme digestion and DNA
sequencing analysis. The expression of CAML protein has
been conﬁrmed by Western blot with single chain variable
region (scFv) antibody. High quality mRNA and cDNA had
been prepared and successful microarray screening had
been conducted. From the scanning results, it was found
7 genes related to cell apoptosis, among them, 4 were
up-regulated and 3 were down-regulated.
Conclusion: The expression of NS4A protein affected the
expression spectrum of 293-CAMLcells, especially some
genes related to cell apoptosis pass way. HCV NS4A maybe
will have some negative effect on the progress of cell
apoptosis, and then lead to the chronic HCV infection.
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prevalence and increase blood safety in Abadan
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Estimated 3% of the world population is infected with
hepatitis C virus and 20% of patients progress to liver
cirrhosis with an increased risk for the development of
hepatocellular carcinoma. In the United States alone, nearly
four million persons are infected and 30,000 acute new
infections are estimated to occur annually. Because the
role of transfusion in HCV transmission and the high number
of blood transfusion dependent patients in Abadan, study of
HCV prevalence in 3 years helps us to evaluating the efﬁcacy
of preventive program in increase the blood safety.
In this descriptive cross sectional survey we studied all
blood donors that referred to Abadan blood center during
